Navigation Links
Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes

turnal hemoglobinuria (PNH) to reduce hemolysis. Alexion is engaged in the discovery and development of therapeutic products aimed at treating patients with severe disease states, including hematologic diseases, cancer and autoimmune disorders, and in May 2007, received a corporate leadership award from the National Organization of Rare Disorders (NORD) for the development of Soliris. Alexion applied for marketing authorization with the European Medicines Evaluation Agency (EMEA) for Soliris in September 2006, and in April 2007 the Committee for Human Medicinal Products (CHMP) of the EMEA adopted a positive opinion recommending marketing authorization for Soliris for the treatment of PNH. This press release and further information about Alexion Pharmaceuticals, Inc. can be found at: http://www.alexionpharm.com.

This news release contains forward-looking statements, including statements related to potential benefits and commercial potential for Soliris, timing for, and potential regulatory decisions with respect to, the marketing applications for Soliris in Europe, and interest and excitement about Soliris in the physician community. Forward-looking statements are subject to factors that may cause Alexion's results and plans to differ from those expected, including for example, requests by regulatory authorities for additional information or data after their review of our submissions, the need for additional research and testing, decision of regulatory authorities not to approve (or to materially limit) marketing of Soliris in Europe or other territories, delays in arranging satisfactory manufacturing capability and establishing commercial infrastructure, delays in developing or adverse changes in commercial relationships, the possibility that results of clinical trials are not predictive of safety and efficacy results of Soliris in broader patient populations, the risk that third parties won't agree
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Studies Show Efficacy and Safety of Alexions Soliris in Broad Population of PNH Patients
2. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
3. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
4. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
5. Gabapentin Shown Effective for Fibromyalgia Pain
6. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
7. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
8. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
9. Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
10. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
11. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
Post Your Comments:
(Date:9/4/2008)...atient Identification for Targeted Therapies ...ment HUNTINGTON BEACH, Calif., and AMSTERDAM, N...ld leader in molecular cancer diagnostics,today a...ostic test that,allows physicians to quantitativel...ogen receptor (ER), progesterone receptor (PR) and...
(Date:9/3/2008)...f Rheumatology Research and Education Foundation,s...ances in Detecting, Treating a.../ -- For the first time during its,unprecedented i... the,American College of Rheumatology Research and... acquired from research funded by the Within Our,R...
(Date:9/3/2008)...hat Multaq(R) (dronedarone) decreased the risk of,...or atrial flutter already adequately ....J., Sept. 3 /- The results...A study were presented today at,the clinical trial...ogy,congress 2008, in Munich, Germany. Previous re...
(Date:9/3/2008)...t. 3 /- A sub-analysis of,t...ment with prasugrel,compared with clopidogrel sign...rt attacks (7.4 percent vs. 9.7 percent, p<0.0001)... the time of an artery-opening,procedure known as ...ey,occurred spontaneously during the longer-term m...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Crdentias National Director of Travel Services Provides an Exclusive Interview on the Growth of Crdentias Travel Nurse Division 2497 1Crdentias National Director of Travel Services Provides an Exclusive Interview on the Growth of Crdentias Travel Nurse Division 2497 2Botched production of insulin molecule may lead to diabetes 625 1Botched production of insulin molecule may lead to diabetes 625 2Botched production of insulin molecule may lead to diabetes 625 3Botched production of insulin molecule may lead to diabetes 625 4New test could help consumers avoid surprise headaches from chocolate wine 622 1New test could help consumers avoid surprise headaches from chocolate wine 622 2New test could help consumers avoid surprise headaches from chocolate wine 622 3Sunnylife Global Retains The Blaine Group For Investor Relations Financial Public Relations 2489 1Sunnylife Global Retains The Blaine Group For Investor Relations Financial Public Relations 2489 2
(Date:9/7/2008)...Upon Students and University Leaders to, Join the ... to Big Tobacco, WASHINGTON, Sept. 8 /PRNewswire-... to aggressive tobacco industry marketing tactics ...ew report released today by the,American Lung Asso...rview of the current status of,tobacco use and pol...
(Date:9/5/2008)...e Latest Developments in Molecular,Testing and Per...Newswire-USNewswire/ -- The practice of,pathology ...d the promise,of personalized medicine will change...other imaging technologies will change the way pat...ts is taking a leadership role in,making sure that...
(Date:9/5/2008)...mane Shows Public Reluctant to Evacuate, Without T...fforts Confirm Survey ...urvey by the American Humane,Association found tha...stance if it meant leaving without their family pe... towards the U.S. coast, residents and,officials s...
(Date:9/5/2008)...to commit to develop a National AIDS,Strategy for ... /PRNewswire-USNewswire/ -- The,Republican Nationa...of the,domestic AIDS epidemic in the United States...as. Neither Presidential nominee Sen. John McCain ...tioned AIDS in their remarks,to Convention delegat...
Breaking Medicine News(10 mins):Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 2Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 3Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 4Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...lished a definite link between risk of pelvic frac...o the study, women who receive radiotherapy for ce...isk// for fracture of the pelvis. This study highl...f cancer treatment in the elderly. Falls are the ...
...e over the safety of artificial sweeteners got an ...trol Council today stated that a rat study conduct...tradictory with the extensive scientific research ...The U.S. Food & Drug Administration (FDA) has said...
...tive groups in the United States, who had voiced v...ailability of the "morning-after" pill, are now ha...ical cancer vaccines.// These vaccines manufacture... still in the experimental stage and are years awa...
...e potential to be the healthcare crisis manager fo...ical tourism, experts say.// Speaking at a health ...dustry (CII) and the Indian Health Care Foundation...uld double the expenditure on healthcare and facil...
Other Medicine News:Health News:Radiation Risk of Pelvic Fracture in Elderly Women 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 3Health News:Religious groups overcome objections to cervical cancer vaccines 2Health News:India Can Manage World’s Healthcare Crisis By 202 2
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: